• 糖尿病足溃疡治疗现况的报告
  • Investigations on Current Global Management of Diabetic Foot Ulcers
  • 王艺霏.糖尿病足溃疡治疗现况的报告[J].中国烧伤创疡杂志,2012,24(4):302.
    DOI:10.3969/j.issn.1001-0726.2012.4.010
    中文关键词:  
    英文关键词:
    基金项目:
    作者单位
    王艺霏 中国烧伤创疡杂志编辑部 
    摘要点击次数: 2443
    全文下载次数: 2518
    中文摘要:
          目前, 糖尿病足溃疡的治疗是一个世界性难题, 医学界普遍使用的治疗方法有: 1) 常规辅料: 凡士林、生理盐水、碘伏、银辅料等; 2) 新型辅料(AMWT) : 藻酸盐、水凝胶、硅胶泡沫等; 3) 物理治疗: 负压引流、高压氧等; 4) 生物辅料: 生长因子、人工皮片等; 5) 手术治疗: 植皮、皮瓣覆盖等。但是, 这些方法存在以下问题: 没有确切疗效, 创面容易感染, 截肢率高, 价格昂贵, 创面愈合后皮肤耐磨性能差等。如今, 皮肤原位再生复原技术(MEBT/ MEBO) 在治疗糖尿病足溃疡方面实现了突破性的进展, 该技术通过为溃疡创面提供生理性湿润环境, 无损伤性地排除液化坏死组织, 持续供给组织器官原位再生复原所需的再生营养物质, 实现了糖尿病足溃疡的生理性再生复原。而且这种方法疗效确切、操作简单、治疗费用低。下图是MEBT/ MEBO 与其它方法治疗糖尿病足溃疡效果的对比病例。报告的相关内容, 请浏览本刊所附DVD。
    英文摘要:
          Presently the treatment of diabetic foot ulcer is an international tough problem and the commonly used approaches in the medical field includes: 1) conventional dressing: Vaseline, NS, iodophor, silver-based dressing, etc. ; 2) Advanced dressing: alginate, hydrogels, hydrocolloids, silicone coated foam, maggot, etc. ; 3) adjunctive strategies: negative pressure wound therapy, hyperbaric oxygen, etc. ; 4) biological dressing: growth factors, artificial skin products, etc. ; 5) surgical methods: skin graft, flap coverage, and etc. However, these approaches result in the following problems such as indefinite therapeutic efficacy, wound infection, higher amputation rate, expensive cost, bad wear-resisting property after wound healing and so on. Nowadays, MEBT/ MEBO has realized the groundbreaking progress in the treatment of diabetic foot ulcer. This approach realizes the physiological regenerative restoration by providing a physiological moist environment, removing and liquefying the necrotic tissues without further damage, and continuously providing regenerative substance needed for the in situ regenerative restoration of tissues/ organs, which can achieve definite therapeutic efficacy and is easy to operate as well as cost less. The pictures below show the outcomes obtained from the approaches of MEBT/ MEBO and the others in treating diabetic foot ulcers for the sake of comparison. As for the more detailed information, please refer to the attached DVD contained in the Journal.